The CPT1A gene helps the liver turn certain fats into energy, especially during fasting, overnight sleep, or illness. If this gene does not work well, the body may struggle to keep blood sugar steady and make ketones, which can lead to tiredness, vomiting, low blood sugar, or liver problems during physical stress. Some people with variants in the CPT1A gene stay well most of the time but become unwell when they go too long without food. Most variants in this gene have little effect, while a small number cause CPT1A deficiency.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or to regulate processes in the body. Some genes carry the directions for producing proteins, the parts of cells that do the work. Other genes mostly help determine when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, and medications. For a more detailed look at this subject, you can find more in the LearnHub.
Overview
CPT1AGene function
What if the gene works
The CPT1A gene helps the liver move long chain fats into mitochondria, the cell’s energy centers. This supports fat burning for energy, especially during fasting or longer gaps between meals.
Risk
What if the gene does not work
More severe variants in the CPT1A gene can cause CPT1A deficiency, where the body struggles to use long chain fats for energy during fasting or illness. This may lead to low blood sugar, liver problems, and sometimes seizures or coma.
Treatment
What does that mean for your treatment
Pathogenic or loss of function variants in both copies of the CPT1A gene guide care toward strict fasting avoidance, regular carbohydrate intake, and rapid glucose support during illness or poor feeding. Some plans also limit long chain fat and use medium chain triglyceride oil because it can bypass the blocked step. No CPT1A specific drug treatment is established.
Conditions associated with CPT1A
Gene function
What if the gene works
Between meals, your body shifts from sugar toward stored fat. The CPT1A gene helps make that switch, especially in the liver. Its protein supports the use of long-chain fats for energy and helps the liver make ketones during fasting or overnight sleep.
Inside liver cells, the CPT1A gene helps prepare long-chain fats to enter mitochondria (the parts of cells that make usable energy). This step lets the body access fat as fuel instead of leaving it stored.
When you go hours without eating, this gene supports the shift toward burning fat for energy. That is a key part of how the CPT1A gene helps the body burn fat during fasting and overnight sleep.
In the liver, the CPT1A gene also supports ketone production from fat. Ketones give the brain and other tissues another fuel source during longer gaps between meals.
What is a variant?
A genetic variant is a small change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CPT1A gene can change the shape, stability, or amount of the CPT1A protein, reducing how well cells move long chain fats into mitochondria (the cell’s energy centers) for energy use. Some variants leave partial activity, while more disruptive variants greatly lower or nearly stop this step. This helps explain how CPT1A gene variants affect protein function and why the functional impact can range from mild to marked. In CPT1A deficiency, lower remaining activity is often linked to earlier or more pronounced symptoms.
How variants are linked to conditions
Pathogenic variants in the CPT1A gene are linked to CPT1A deficiency, a rare inherited condition that can cause low blood sugar after going long without food, liver problems, and illness in infancy or childhood. Finding disease-causing variants in both copies of the CPT1A gene can confirm the diagnosis. Among some Arctic Indigenous populations, the CPT1A p.Pro479Leu variant has been linked to a higher chance of problems during fasting or infection, although many people carrying this variant do not become ill.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widespread in the general population. Most do not directly affect health and instead reflect normal human variation. For many genes, having a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with harmful changes in both copies of the CPT1A gene, risk is driven mainly by the gene change itself. Long gaps without food, infections with fever, and cold exposure can raise the chance of low blood sugar and a metabolic crisis. Early feeding plans and sick-day care help lower the risk of serious complications.
Inheritance of CPT1A variants
Variants in the CPT1A gene linked to CPT1A deficiency are inherited in an autosomal recessive pattern. This means a child usually inherits one changed copy of the CPT1A gene from each parent. Parents who each carry one variant are typically unaffected carriers, and with each pregnancy there is a 25% chance the child inherits both variants, a 50% chance the child is a carrier, and a 25% chance the child inherits neither variant. In families looking into how CPT1A gene variants are inherited, this also means the condition can affect children of any sex equally.
What does my CPT1A result mean for my family?
For families affected by CPT1A deficiency, close relatives may also carry the changed CPT1A gene, even if they feel well. Brothers and sisters may also be affected or be carriers, and parents are usually carriers. Family members may want to review their own chance of carrying the gene change, especially when planning children.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the CPT1A gene, genetic testing for CPT1A variants uses a blood or saliva sample. A lab reads the DNA code and checks for variants, then reports whether a relevant change was found, not found, or needs more interpretation.
When should I consider getting a genetic test?
Consider testing for the CPT1A gene if a baby or child has repeated low blood sugar during fasting or illness, low ketone levels, liver problems, or a newborn screen suggests this condition. Testing can also help if CPT1A-related illness runs in the family or if parents want carrier testing before pregnancy.
A genetic result is only one part of your health story
Genetic test results can provide useful insight, but how much they show depends on the condition and the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. One person may break down a drug more slowly or more quickly than another, which can change how well the treatment works or how likely side effects are. These differences are common and are one reason the same medication can feel helpful for one person but not work the same way for someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape the way people respond to medications. By studying links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can support more informed, individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the CPT1A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted, so questions about new symptoms, side effects, or medication changes are best discussed with your doctor or pharmacist.
History
Researchers first recognized carnitine palmitoyltransferase as an important enzyme system in the mid 20th century, and later showed that the liver form was encoded by the CPT1A gene. In the 1990s, families with recurrent low blood sugar during illness helped connect pathogenic variants in the CPT1A gene with a distinct inherited condition. From these first observations, research expanded steadily. Newborn screening programs then brought wider clinical attention to the gene because some affected infants could be identified before a crisis occurred. The CPT1A gene also became an important focus in Arctic and Alaska Native health research after a common regional variant was described. That work shaped ongoing discussions about population history, screening, and culturally informed care.